Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
144 participants
INTERVENTIONAL
2021-12-12
2025-01-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary objective of the study is to assess the impact of EEN on postoperative morbidity after PD, according to the Comprehensive Complication Index. Secondary objectives are to assess the impact of EEN on major postoperative complications, according to Clavien classification, specific complications, length of stay, readmission rates, quality of life, metabolic stress and nutritional response after PD.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Postoperative Artificial Nutrition After Pancreaticoduodenectomy
NCT01580527
Early Enteral Feeding After Pylorus Preserving Pancreatoduodenectomy
NCT00809081
Pancreatic Resection, Malnutrition and Readmission
NCT01947166
Early Oral Versus Enteral Nutrition After Pancreatoduodenectomy
NCT01642875
Early Oral Intake After Pancreaticoduodenectomy in the Age of ERAS
NCT02941484
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early enteral nutrition
Intervention group: enteral nutrition from the first postoperative night until 50% of caloric requirements are covered by oral nutrition. Enteral nutrition will start at a flow of 250 ml/12h. If tolerated, enteral nutrition will be increased to 500 ml/12h on postoperative day 1, 750 ml/12h on postoperative day 2, and 1000 ml/12h on postoperative day 3. A hypercaloric enteral nutrition will be used (Isosource Energy Fibre or similar).
Early enteral nutrition
Enteral nutrition via nasojejunal tube
Oral nutrition
Control group: patients will receive standardized oral nutrition. The night after the operation, patients will be allowed to have free drinks. On postoperative day 1, they will receive bouillons, creams, yogurts, and drinks \>2 l. On postoperative day 2, they will receive a light diet. On postoperative day 3, they will receive half portion of normal diet and on postoperative day 4 normal diet.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Early enteral nutrition
Enteral nutrition via nasojejunal tube
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient ≥18 years old.
* Patient at nutritional risk, i.e., with Nutrition Risk Screening (NRS) ≥3.
* Signed informed consent.
Exclusion Criteria
* Enteral feeding already initiated preoperatively.
* Language barrier.
* Inability to follow the procedures of the study, e.g., due to language problems, psychological disorders (i.e., eating disorders and bipolar disorders), or dementia.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Lausanne Hospitals
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gaëtan-Romain Joliat
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gaëtan-Romain Joliat, MD
Role: PRINCIPAL_INVESTIGATOR
University of Lausanne Hospitals
Markus Schäfer, MD
Role: STUDY_DIRECTOR
University of Lausanne Hospitals
Nicolas Demartines, MD
Role: STUDY_CHAIR
University of Lausanne Hospitals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Cochin-Port Royal, AP-HP
Paris, , France
Lausanne University Hospital (CHUV)
Lausanne, Canton of Vaud, Switzerland
Regional Hospital of Lugano
Lugano, Canton Ticino, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Joliat GR, Martin D, Labgaa I, Melloul E, Uldry E, Halkic N, Fotsing G, Cristaudi A, Majno-Hurst P, Vrochides D, Demartines N, Schafer M. Early enteral vs. oral nutrition after Whipple procedure: Study protocol for a multicentric randomized controlled trial (NUTRIWHI trial). Front Oncol. 2022 Jun 28;12:855784. doi: 10.3389/fonc.2022.855784. eCollection 2022.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-00724
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.